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To explore the physiological functions of endothelin-2 (ET-2), we generated gene-targeted mouse models. 
Global Et2 knockout mice exhibited severe growth retardation and juvenile lethality. Despite normal milk 
intake, they suffered from internal starvation characterized by hypoglycemia, ketonemia, and increased 
levels of starvation-induced genes. Although ET-2 is abundantly expressed in the gastrointestinal tract, 
the intestine was morphologically and functionally normal. Moreover, intestinal epithelium–specific Et2 
knockout mice showed no abnormalities in growth and survival. Global Et2 knockout mice were also pro-
foundly hypothermic. Housing Et2 knockout mice in a warm environment significantly extended their 
median lifespan. However, neuron-specific Et2 knockout mice displayed a normal core body temperature. 
Low levels of Et2 mRNA were also detected in the lung, with transient increases soon after birth. The lungs 
of Et2 knockout mice showed emphysematous structural changes with an increase in total lung capacity, 
resulting in chronic hypoxemia, hypercapnia, and increased erythropoietin synthesis. Finally, systemically 
inducible ET-2 deficiency in neonatal and adult mice fully reproduced the phenotype previously observed 
in global Et2 knockout mice. Together, these findings reveal that ET-2 is critical for the growth and survival 
of postnatal mice and plays important roles in energy homeostasis, thermoregulation, and the maintenance 
of lung morphology and function.
Introduction
The endothelin (ET) system comprises three 21-residue active 
peptides (ET-1, -2, and -3), two G protein–coupled receptors (ETA 
and ETB), and activating peptidases including the ET-converting 
enzymes (ECE-1 and -2) (1). The developmental and (patho)phys-
iological roles of the ET system components have been extensively 
studied using gene-targeted mice. The ET-1/ECE-1/ETA pathway 
is essential for the development of pharyngeal arch–derived, cran-
iofacial, and cardiac tissues (2, 3), whereas the ET-3/ECE-1/ETB 
pathway is essential for the development of the enteric nervous 
system and skin melanocytes (4, 5). Although Ece-2–null mice 
revealed no marked abnormalities (6), Ece-1/Ece-2 double mutants 
exhibited more severe cardiac abnormalities, including endocar-
dial cushion defects (7). These molecular genetic studies point to 
the highly local action of ETs. For example, although ET-1 (which 
is produced by vascular endothelial cells and other cell types) is 
distributed widely in all tissues, the peptide cannot prevent the 
phenotype of ET-3 deficiency, indicating that ET-3 produced in 
the immediate vicinity of the relevant target cells (i.e., enteric neu-
roblasts expressing the ETB receptor) is essential.
In addition, specific roles of the ET system in heart and kidney 
have been investigated using the Cre/loxP system. Although car-
diomyocyte-specific ET-1 mediates cardiac hypertrophy induced 
by thyroid hormone (8), the ETA receptor is not necessary for either 
basal cardiac function or stress-induced response to angiotensin II 
or isoproterenol (9). Collecting duct–specific inactivation of ET-1 
(10), ETA receptor (11), ETB receptor (12), as well as both ETA and 
ETB receptors (13) revealed the importance of the ET system in 
maintaining blood pressure and regulating sodium excretion.
Unlike other components of the ET system, very little is known 
about the biological function of endogenous ET-2. Although 
ET-2 is pharmacologically indistinguishable from ET-1, with 
equally high affinities for both ETA and ETB receptors, the tissue 
distribution of ET-2 is highly limited; ET-2 is most abundantly 
expressed in the intestine, suggesting a role in the gastrointestinal 
tract. Recently, a specific expression pattern of ET-2 in intestine 
and its possible roles in the maintenance of villous architecture 
have been hypothesized (14). In addition, several other potential 
roles of ET-2 have been proposed. Et2 mRNA is strongly induced 
in photoreceptor cells in retinal diseases and injury, which may 
function as a stress signal to Muller cells through ETB (15). ET-2 
is produced by microglia and macrophages in the early stages of 
a mouse glaucoma model, which suggests a novel link between 
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microglia/macrophages and vascular dysfunction in glaucoma 
(16). During the ovulatory process, ET-2 is transiently produced 
in granulosa cells of the preovulatory follicles and induces fol-
licular rupture through the ETA receptor (17). In the field of 
tumor biology, ET-2 may serve as a marker for uveal melanoma 
(18) and is highly induced by hypoxia in squamous carcinoma 
cell lines derived from pharynx and cervix (19). ET-2 may also act 
as a chemoattractant for macrophages in tumors (20) and as an 
inducer of invasion (21) and a survival factor for breast tumor 
cells (22). ET-2 expression is upregulated in the early-stage clear 
cell subtype of renal cell carcinoma, suggesting a putative role in 
clear cell renal cell carcinoma progression (23).
In order to directly assess the in vivo role of ET-2 in mice, 
we generated constitutive and conditional Et2-deficient strains 
and comprehensively analyzed the phenotypes. The results 
reveal multiple essential roles of ET-2 in the growth and sur-
vival of postnatal mice.
Results
Tissue distribution of Et2 mRNA. ETs function as highly local and 
paracrine/autocrine mediators (1). Therefore, identification of 
ET-2–expressing tissues and cell types is critical to understanding 
its physiological function. As previously reported (24), Et2 mRNA 
is abundantly expressed in the upper and lower gastrointestinal 
tract (Figure 1A). Et2 is also detected at lower levels in a number 
of tissues including the brain, lung, pancreas, testis, and ovary. 
During the embryonic period, Et2 mRNA expression is markedly 
increased from E15 and remains roughly constant until birth 
Figure 1
Expression profile of Et2 mRNA. 
(A) qRT-PCR analysis of Et2 
mRNA expression in individ-
ual tissues and time course in 
the embryo and lung (n = 5). 
Values are presented as fold 
change relative to ET-2 expres-
sion in E10 (whole embryo), 
BAT (thermoregulatory tissues), 
P20 (lung), and muscle (whole 
tissues). (B and C) Localization 
of ET-2, ETA, and ETB in small 
intestine. In situ hybridization 
was performed with 35S-labeled 
probes in the mouse ileum. (B) 
Representative photographs 
shown by dark-field microscopic 
imaging. Original magnification, 
×20. Constitutive Et2-null mouse 
(KO) was used as a negative 
control. (C) Representative pho-
tographs shown by bright-field 
microscopic imaging. Origi-
nal magnification, ×40. Black 
dots indicate the localization of 
genes, and arrows show specific 
localization of ET-2 in the villous 
and crypt epithelium, and ETA 
and ETB in the lamina propria.
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(Figure 1A, whole embryo). Intestinal ET-2 is responsible for 
most Et2 expression in the whole embryo at E15 (Supplemental 
Figure 1; supplemental material available online with this article; 
doi:10.1172/JCI66735DS1). Et2 mRNA is also present in ther-
moregulatory tissues such as brainstem, spinal cord, pituitary, 
adrenals, and thyroid at low but detectable levels (Figure 1A; ther-
moregulatory tissues). In the lung, Et2 mRNA is transiently and 
markedly increased shortly after birth (Figure 1A; lung). In situ 
hybridization in the ileum of the small intestine revealed that Et2 
mRNA is specifically expressed in the villous and crypt epithelium. 
In contrast, the Eta and Etb receptor mRNAs are located in the 
lamina propria below the epithelium (Figure 1, B and C).
ET-2 is essential for the growth and survival of postnatal mice. Constitu-
tive Et2-null mice were generated by replacing a portion of exon 1 
and all of exon 2 encoding the mature ET-2 peptide with the neo 
cassette (Supplemental Figure 2A). The absence of Et2 mRNA 
was confirmed by quantitative RT-PCR (qRT-PCR) because ET-2 
is immunologically indistinguishable from ET-1 (Figure 2A). 
Constitutively Et2-null mice were born healthy with expected 
Mendelian frequencies. Out of 154 pups examined, there were 40 
Figure 2
Essential role of ET-2 in growth and survival of postnatal mice. (A) qRT-PCR analysis demonstrating an absence of Et2 mRNA in individual tissues 
of constitutive Et2-null mice (n = 5). Values are presented as fold change relative to ET-2 expression in stomach from WT mice. (B) Body weight 
during pre-weaning period of constitutive Et2-null and littermate WT mice (n = 15). Inset shows a representative photograph of Et2-null (right) and 
WT (left) mice at 2 weeks of age. (C) Survival ratio of constitutive Et2-null and littermate WT mice (n = 100–102). (D) qRT-PCR analysis demon-
strating an absence of Et2 mRNA level in individual tissues of neonatal and adult Et2f/f;CAGGCre-ERTM mice (n = 5). Values are presented as 
fold change relative to ET-2 expression in lung from adult Et2f/f control mice. ND, not detected. (E and F) Body weight (E) and survival ratio (F) of 
neonatal Et2f/f;CAGGCre-ERTM and littermate control Et2f/f mice (n = 9–17). (G) Body weight of adult Et2f/f;CAGGCre-ERTM and control littermate 
Et2f/f mice (n = 9–10). (H) Fat content of adult Et2f/f;CAGGCre-ERTM and littermate control Et2f/f mice after 10 weeks of tamoxifen (TAM) injection 
(n = 9–10). *P < 0.05; **P < 0.01; #P < 0.001.
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(26.0%) Et2+/+, 72 (52.6%) Et2+/–, and 42 (27.2%) Et2–/– mice. At P3, 
the appearance and size of the Et2-null pups were similar to their 
WT littermates. Although Et2-null pups were frequently observed 
being nursed and normal amounts of milk were found in the 
stomach (Supplemental Figure 3), by P5, Et2-null mice failed to 
thrive and displayed severe growth retardation (Figure 2B). The 
mutant mice eventually died by 3 to 4 weeks of age (Figure 2C).
Despite the obvious postnatal phenotype of constitutive Et2-
null mice, ET-2 expression is increased from E15 (Figure 1A). 
Hence, to examine when the presence of ET-2 is important for 
growth and survival between the embryonic and postnatal peri-
ods, we generated systemically inducible Et2-null mice by cross-
ing mice with loxP-flanked ET-2 (Et2f/f) (Supplemental Figure 2B) 
with mice harboring Cre-ERTM recombinase driven by a chime-
ric promoter of the cytomegalovirus immediate-early enhancer 
and chicken β-actin promoter/enhancer (CAGG) (25). Reduced 
expression of Et2 mRNA in Et2f/f;CAGGCre-ERTM mice on P0 by 
gavage feeding of tamoxifen to the dam (neonatal Et2f/f;CAGGCre-
ERTM) or at 6 weeks of age following intraperitoneal injection of 
tamoxifen (adult Et2f/f;CAGGCre-ERTM) was confirmed by qRT-
PCR in the brain, lung, small intestine, and colon (Figure 2D). 
Neonatal Et2f/f;CAGGCre-ERTM mice fully recapitulated the phe-
notype of constitutive null mice: growth retardation (Figure 2E) 
and early lethality (Figure 2F). Adult Et2f/f;CAGGCre-ERTM mice 
also showed diminished weight gain (Figure 2G). Fat mass of 
adult Et2f/f;CAGGCre-ERTM mice was consistently decreased after 
10 weeks of ET-2 inactivation (Figure 2H), although removal of 
ET-2 in the adult did not cause early lethality. Taken together, 
these results indicate that ET-2 is essential for growth regulation 
and survival of postnatal mice and the maintenance of energy 
homeostasis even in adulthood.
Et2-null mice are internally starved. To gain insight into the mecha-
nism of this intriguing phenotype, we analyzed blood parameters 
of constitutive Et2-null mice at the age of 2 weeks. Overall, there 
was no significant difference between the genotypes. However, 
blood glucose levels were strikingly low in Et2-null mice under the 
fed condition (Supplemental Table 1), and this was maintained 
at all ages (Figure 3A). Blood urea nitrogen (BUN) and uric acid 
levels were significantly elevated, suggesting an increased catabolic 
response to energy deprivation (Supplemental Table 1). Despite 
the low blood glucose concentrations, insulin levels of Et2-null 
mice were not significantly different from those of WT controls 
and were normally regulated in both fed and fasted conditions 
(Supplemental Figure 4A). Although mild, T3 levels were reduced 
in the mutant mice, implicating a decreased metabolic rate for 
these animals (Supplemental Figure 4B). Since thyroid hormone 
is important in maintaining the basal level of metabolism and neo-
natal growth, we attempted to rescue the abnormal growth and 
survival of Et2-null mice by thyroid hormone replacement. Neither 
growth retardation nor early lethality was improved, however, by 
T3 supplementation (Supplemental Figure 5).
The results of normal milk consumption (Supplemental Figure 3) 
and blood chemistry (Supplemental Table 1) indicate that consti-
tutive Et2-null mice suffered from apparent internal starvation. In 
order to verify this, we measured the expression of genes known 
to be induced by starvation. As expected, mRNA expression of 
phosphoenolpyruvate carboxykinase 1 (Pck1) and pyruvate dehy-
drogenase kinase isozyme 4 (Pdk4), key gluconeogenic enzymes, 
was upregulated in the liver of Et2-null mice (Figure 3B). Expres-
sion of hydroxymethylglutaryl-CoA synthase 2 (Hmgcs2), which 
catalyzes a key step in ketone body synthesis (Figure 3B), and the 
concentration of serum total ketone bodies were also elevated 
in Et2-null mice compared with WT mice (Figure 3C). Further-
more, expression of fibroblast growth factor 21 (Fgf21), which was 
recently discovered as a key regulator of the body’s adaptation to 
fasting (26), was significantly induced in the liver of constitutive 
Et2-null mice (Figure 3B). Neonatal and adult Et2f/f;CAGGCre-ERTM 
mice also exhibited significantly lower blood glucose levels than 
the controls (Figure 3D). These data suggest that ET-2 deficiency 
contributes to an internally starved state in mice, and this may be 
the critical underlying mechanism for the growth retardation and 
early lethality of Et2-null mice.
Intestinal ET-2 is not essential for growth regulation and survival of 
mice. The internally starved phenotype, abundant expression of 
Et2 mRNA in the gut, and local activity of ET strongly support a 
hypothesis by which intestinal dysfunction leading to malabsorp-
tion and/or malnutrition could cause the internally starved state 
of the Et2-null mice. To test this hypothesis, we first examined 
nutrient management. We found that fat absorption, measured 
by the amount of [3H] triolein present in the small intestine and its 
Figure 3
Internally starved state of Et2-null mice. (A) Blood glucose levels of constitutive Et2-null and littermate WT mice at the indicated age (n = 10). (B) 
Expression of starvation-induced genes in constitutive Et2-null and littermate WT mice at 2 weeks of age. qRT-PCR was performed using mRNAs 
extracted from liver (n = 4). Values are presented as fold change relative to ET-2 expression in WT control mice. (C) Serum total ketone levels of 
constitutive Et2-null and littermate WT mice at 2 weeks of age (n = 4). (D) Blood glucose levels of neonatal Et2f/f;CAGGCre-ERTM (2-week-old), 
adult Et2f/f;CAGGCre-ERTM (6-week-old) and their littermate control Et2f/f mice (n = 10). *P < 0.05; **P < 0.01; #P < 0.001.
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content after oral gavage, was similar in control and constitutive 
Et2-null mice (Figure 4A, left). In addition, the proportion of fat 
and carbohydrate in feces did not exhibit any apparent difference 
in Et2-null mice (Figure 4A, right). Finally, as measured by qRT-
PCR, mRNA levels of genes responsible for digestion and absorp-
tion of fat, carbohydrate, and protein were not significantly altered 
in the intestines of constitutive Et2-null mice compared with WT 
controls (Supplemental Figure 6).
To directly address the role of enterocytic ET-2, we generated 
intestinal epithelium–specific Et2-null mice by crossing Et2f/f mice 
with mice carrying Cre recombinase driven by the villin (Vil) pro-
moter (27). Intestinal epithelium–specific recombination of the 
loxP sites was verified by PCR with genomic DNA (Supplemen-
tal Figure 7), and loss of Et2 mRNA expression was confirmed 
by qRT-PCR in different parts of the intestine (Figure 4B). The 
level of Et2 mRNA was unchanged in other organs, including the 
stomach, since the villin promoter is inactive in the stomach as 
previously reported (ref. 27, Supplemental Figure 7, and Figure 
4B). Et2f/f;Vil-Cre mice were born healthy and, unlike the consti-
tutive and inducible Et2-null mice, no defects in growth (Figure 
4C) or blood glucose levels (Figure 4D) were observed. Moreover, 
as shown in constitutive Et2-null mice, neither fat absorption nor 
excretion of fats and carbohydrates in feces significantly changed 
in the Et2f/f;Vil-Cre mice (Figure 4E). It is unlikely that ET-1 or ET-3 
is compensating for the loss of ET-2, since the expression of Et1 
and Et3 mRNA was unchanged in the small intestine of constitu-
tive and intestinal epithelium–specific Et2-null mice (Supplemen-
tal Figure 8). Therefore, contrary to our original hypothesis that 
ET-2 may play an important role in the (patho)physiology of the 
intestine, these data reveal that the intestine is not an essential site 
of ET-2 action under normal physiological conditions.
Since stomach Et2 mRNA expression is intact (Figure 4B and 
Supplemental Figure 7) and no significant abnormality was 
observed in Et2f/f;Vil-Cre mice (Figure 4, C and D), it seemed plausi-
ble that pH and enzyme secretion in the stomach could be affected 
by global ET-2 deficiency. The pH of stomach content from con-
stitutive Et2-null mice was more acidic (pH≈3–4) compared with 
WT controls (pH≈5–6), perhaps contributing to enhanced protein 
denaturation. Therefore, we first examined mRNA levels for key 
proteins regulating acidification, protein digestion, or milk coag-
ulation in the stomach and found that the expression of these 
genes was not significantly different between stomach samples of 
WT and constitutive Et2-deficient mice (Supplemental Figure 9). 
To determine whether the abnormal growth rate is caused by 
the aberrant digestion and/or absorption of nutrients due to an 
altered stomach pH, we provided the mice with sodium bicar-
bonate in drinking water to neutralize the stomach pH. However, 
no improvement in lifespan of the constitutive Et2-null mice was 
observed (Supplemental Figure 10). Among the numerous ET-2–
expressing tissues, Et2 mRNA expression was detected in whole 
Figure 4
No detectable abnormalities in energy-related processes of constitutive and intestinal epithelium–specific Et2-null mice. (A) Dietary fat absorption 
(left) and excretion of fats and carbohydrates (right) of 6-week-old “rescued” constitutive Et2-null and littermate WT mice (n = 5). (B) qRT-PCR 
analysis demonstrating intestine-specific deletion of Et2 by villin promoter–driven Cre recombinase (n = 5). Values are presented as fold change 
relative to ET-2 expression in stomach from control Et2f/f mice. (C) Body weight of Et2f/f;Vil-Cre and their littermate control Et2f/f mice (n = 21–23). 
(D) Blood glucose levels of Et2f/f;Vil-Cre and their littermate control Et2f/f mice at 2 weeks of age (n = 10). (E) Dietary fat absorption (left) and excre-
tion of fats and carbohydrates (right) of 6-week-old Et2f/f;Vil-Cre mice and their littermate controls (n = 5). ND, not detected; NS, nonsignificant.
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pancreas, albeit at relatively low levels (Figure 1A; whole tissues). 
Because insulin secretion is normal in constitutive Et2-null mice 
(Supplemental Figure 4A), we analyzed the expression of exocrine 
pancreatic enzymes. However, mRNA levels of genes involved 
in the digestion and absorption of fat, carbohydrate, and pro-
tein were not significantly 
changed in the constitutive 
Et2-null mice compared 
with the WT controls (Sup-
plemental Figure 11).
Defective thermoregulation 
of Et2-null mice. Constitu-
tive Et2-null mice exhibited 
mild hypothermia, which 
could be a consequence of 
internal starvation (Figure 
5A; group-housed). When 
Et2-null mice were sepa-
rated for 3 hours from the 
dam and siblings, the core 
body temperature of the 
Et2-null mice drastically 
declined to 25.9 ± 0.6°C 
(versus 36.5 ± 0.2°C for 
the WT controls) at room 
temperature (Figure 5A; 
isolated). Thus, we exposed 
constitutive Et2-null mice 
to a cold environment to 
examine whether ET-2 is 
important for heat gener-
ation and conservation. 
Although the control mice 
maintained a body temper-
ature within a 2.2°C range, 
the core body temperature 
of Et2-null mice dropped to 
approximately 22°C within 
5 hours of exposure to 4°C 
(Figure 5B). Type 2 iodothy-
rosine deiodinase (DIO2) is 
activated during cold stress 
to increase triiodothyro-
ine (T3) concentration in 
brown adipose tissue (BAT) 
(28). The level of uncou-
pling protein 1 (UCP1), the 
key thermogenic regulator 
in BAT, is regulated by T3 
(29). Therefore, we exam-
ined the expression of DIO2 
and UCP1 to determine 
whether ET-2 deficiency 
affects these genes and 
leads to defects in thermo-
genesis. As expected, Dio2 
and Ucp1 mRNA levels were 
significantly reduced in the 
BAT of cold-exposed consti-
tutive Et2-null mice (Figure 
5C). Histological analysis also revealed abnormalities, including 
reduced nuclei number and a marked accumulation of large lipid 
vacuoles, suggesting that there is no apparent increase in lipolysis 
to generate heat (Supplemental Figure 12). Low body tempera-
ture induces behavioral responses in mice, such as huddling in a 
Figure 5
Defective thermoregulation of Et2-null mice. (A) Core body temperature of group-housed and isolated 3-week-
old constitutive Et2-null mice (n = 10). (B) Core body temperature of 6-week-old “rescued” constitutive Et2-null 
and littermate WT mice in cold environment (n = 6). (C) qRT-PCR of Dio2 and Ucp1 mRNA levels in BAT 
from 6-week-old “rescued” constitutive Et2-null and littermate WT mice after 5 hours of cold exposure (n = 4). 
Values are presented as fold change relative to ET-2 expression in control WT mice. (D) Temperature choice 
test of 6-week-old “rescued” constitutive Et2-null and littermate WT mice (n = 14–21). (E) Survival ratio of 
constitutive Et2-null mice housed in warm (33°C) and ambient (22°C) environment from 3 weeks of age 
(n = 20–21). (F) Core body temperature of neonatal (2-week-old) and adult Et2f/f;CAGGCre-ERTM (6-week-old) 
mice, and littermate control Et2f/f mice at ambient temperature (n = 7–10). (G) Core body temperature of adult 
Et2f/f;CAGGCre-ERTM and control mice in a cold environment at 6 weeks of age (n = 10). (H) qRT-PCR of Ucp1 
mRNA levels in BAT from adult Et2f/f;CAGGCre-ERTM and littermate control Et2f/f mice after 12 hours of cold 
exposure (n = 4). (I) qRT-PCR analysis demonstrating brain-specific deletion of Et2 by nestin promoter-driven 
Cre recombinase. (J) Core body temperature of Et2f/f;Nes-Cre and littermate control Et2f/f mice at 6 weeks of 
age (n = 5). *P < 0.05; **P < 0.01; #P < 0.001.
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Figure 6
Impaired lung morphology and function of Et2-null mice. (A and B) qRT-PCR was performed using mRNAs extracted from isolated epithelial and 
mesenchymal cell populations of rat lung to examine the purity of cell fractions (A) and expression of ET-2, ETA, and ETB (B) (n = 3–5). Values 
are presented as fold change relative to gene expression in epithelium for Krt18, Et2, Eta, and Etb, and in mesenchyme for Vim. (C) Histological 
phenotypes of the lungs of Et2-null and littermate WT mice. Lung sections from constitutive Et2-null (P1-P21) and adult Et2f/f;CAGGCre-ERTM 
(8-week-old) mice and their control littermates were stained with H&E. Original magnification, ×10. (D) Blood gas of constitutive Et2-null (2-week-
old) and adult Et2f/f;CAGGCre-ERTM (8-week-old) mice and their control littermates (n = 6). (E–G) Levels of erythropoietin (Epo) mRNA in kidneys 
(left) and protein in serum (right) (E), hematocrit (Hct) (F) level, and total lung capacity (G) of constitutive Et2-null and control littermate mice at 
3 weeks of age (n = 5). *P < 0.05; **P < 0.01; #P < 0.001.
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curled posture and seeking a warmer place. A stationary curled 
posture was notably seen in constitutive Et2-deficient mice. 
When WT and Et2-deficient mice were placed in an apparatus 
with 2 available thermal zones (22°C versus 33°C), there was an 
apparent difference in the amount of time spent in each zone. 
Unlike the cold-zone preference of WT mice, Et2-null mice clearly 
sought a warmer location (Figure 5D).
The thermoregulatory defect results of constitutive Et2-null mice 
led us to hypothesize that placing Et2-null mice at a higher ambient 
temperature might delay their premature death. To test this possi-
bility, 1 group of 3-week-old constitutive Et2-null mice was housed 
at room temperature, while the second group was placed on a 33°C 
heating plate for added warmth. The Et2-null mice housed at the 
higher temperature lived significantly longer — in fact, median life-
span was extended from 4 weeks to 9 weeks (Figure 5E).     
Consistent with global Et2-null mice, neonatal and adult Et2f/f; 
CAGGCre-ERTM mice were also mildly hypothermic at ambient 
temperature (Figure 5F). To examine whether ET-2 deficiency 
in adulthood is also important for heat generation and conser-
vation, adult Et2f/f;CAGGCre-ERTM mice and their control litter-
mates were challenged with a cold environment. Control Et2f/f 
mice maintained their core body temperature within a 1.2°C 
range over a 12-hour period of cold exposure (38.0 ± 0.15°C versus 
36.8 ± 0.31°C; Figure 5G). However, as shown in constitutive 
Et2-null mice, the core body temperature of adult Et2f/f;CAGGCre-
ERTM mice significantly dropped after 12 hours of cold exposure 
(36.9 ± 0.3°C versus 34.7 ± 0.5°C; Figure 5G). Greater body weight 
(25 g) and a decreased surface/volume ratio may partially explain 
why hypothermia was not as extreme in adult Et2f/f;CAGGCre-ERTM 
mice compared with constitutive Et2-null mice (10 g, 6-week-old 
mice rescued from a warm environment). Ucp1 mRNA levels in 
BAT from cold-exposed adult Et2f/f;CAGGCre-ERTM mice were also 
downregulated (Figure 5H).
ET-2 might be involved in central thermoregulation because: (a) 
despite the profound hypothermia, DIO2 and UCP1 expression is 
reduced in mutant mice (Figure 5C); (b) thermogenesis of BAT is 
activated by the hypothalamus via the sympathetic nervous system 
(30); and (c) Et2 mRNA is present in the brainstem and spinal cord 
but not in BAT (Figure 1A; thermoregulatory tissues). To directly 
examine this possibility, we generated neuron-specific Et2-null 
mice by crossing Et2f/f mice with mice carrying Cre recombinase 
driven by the nestin (Nes) promoter. Loss of Et2 mRNA expression 
in the brain was verified by qRT-PCR (Figure 5I). Et2f/f;Nes-Cre mice 
were born healthy, and no growth defects were observed (Supple-
mental Figure 13). Moreover, unlike constitutive Et2-null mice, the 
neuron-specific Et2-null mice displayed normal core body tem-
perature (Figure 5J; 4°C at 0 hours), even in a cold environment 
(Figure 5J; 4°C at 12 hours). These results suggest that aberrant 
thermoregulation in constitutive Et2-null mice is not a result of 
the loss of ET-2 expression in the central nervous system.
Compromised lung morphology and function in Et2-deficient mice. 
We often observed breathing difficulties in constitutive Et2-null 
mice, with audible wheezing from the age of 1 week onward. Con-
sistent with a previous report (31), we found that Et2 mRNA is 
expressed at a low level in the lung and exhibits a transient increase 
at birth (Figure 1A; lung). In order to identify the ET-2–expressing 
cell types in the lung, we performed qRT-PCR using isolated epi-
thelial and mesenchymal cell populations from rat lung (E19.5). 
The purity of the fractions was confirmed by qRT-PCR of cyto-
keratin-18 (Krt18) and vimentin (Vim) for epithelium and mes-
enchyme, respectively. Very low levels of Vim mRNA in the epithe-
lial fraction reflect a minor contamination of fibroblasts (Figure 
6A). Expression of Et2 mRNA was only detected in the epithelial 
fraction. In contrast, the Eta and Etb mRNAs are predominantly 
expressed in the mesenchyme, possibly indicating a paracrine 
function for ET-2 in the lung (Figure 6B). The expression pattern 
strongly indicates that ET-2 might be involved in postnatal lung 
development and may mediate specific interactions between epi-
thelial and mesenchymal cells.
Histological analyses of the lung displayed severe abnormalities 
in postnatal lung alveogenesis. The lungs of constitutive Et2-null 
mice exhibited enlarged air spaces with substantial simplification 
of lung alveolar structure compared, with WT controls (Figure 
6C; P0-P21). Similar morphological changes were also observed in 
adult Et2f/f;CAGGCre-ERTM mice (Figure 6C; Adult). These data sug-
gest that ET-2 is critical not only for postnatal lung development, 
but also for the maintenance of lung structure in adulthood.
To examine the physiological and functional relevance of these 
morphological abnormalities, we first examined blood gases. Par-
tial pressure of carbon dioxide (pCO2) was elevated in both con-
stitutive Et2-null mice and adult Et2f/f;CAGGCre-ERTM mice. As a 
result of hypercapnia, blood pH was more acidic, and bicarbonate 
(HCO3–) levels were clearly elevated in both Et2 mutant lines. The 
oxygen saturation percentage of arterial hemoglobin (SpO2) in 
Et2-null mice was markedly decreased, revealing hypoxemia (Fig-
ure 6D). Consistent with the decrease in SpO2, mRNA synthesis 
of erythropoietin (Epo) in the kidneys was induced. EPO protein 
levels in serum were significantly increased in the Et2-null mice 
(Figure 6E), likely resulting in an increase in plasma hematocrit 
(Figure 6F). As a consequence of altered structure, the lungs of 
Et2-null mice had larger total lung capacities compared with WT 
controls (Figure 6G). These results indicate that the morpholog-
ical abnormalities of Et2-deficient lungs may lead to hypercapnia 
and hypoxemic hypoxia in Et2-null mice.
Discussion
In the present study, we explore the biological function of ET-2 
using knockout mouse models. Mice with constitutive or system-
ically-induced deletion of ET-2 exhibited defective energy homeo-
stasis, thermoregulation, and lung morphology and function. Our 
comprehensive analyses, including the examination of tissue-spe-
cific knockouts, show that intestinal and neuronal ET-2 is not fully 
accountable for the regulation of energy homeostasis and body 
temperature, respectively. The dramatic effects of ET-2 deficiency 
in the lung are newly discovered and the lung may therefore be an 
important site for critical ET-2 action. In the lung, Et2 mRNA is 
expressed in epithelial cells and transiently increased soon after 
birth. Temporary induction of Et2 mRNA by pathological or phys-
iological stimuli is also observed in the photoreceptor cells of the 
retina (15) and the granulose cells of the ovary (17). The analysis 
of lung-specific Et2-deficient mice will help to determine whether 
ET-2 expression in the lung is critical for the growth regulation 
and survival of postnatal mice. Lung epithelium is composed of 
several specific cell types such as squamous alveolar (type I) and 
great alveolar (type II) cells in the alveolar epithelium, and ciliated 
cells and Clara cells in the respiratory bronchioles. Cell type–spe-
cific gene promoters expressing Cre are available for each lung 
epithelial cell population: surfactant protein C (SP-C) for type II 
cells, Clara cell secretory protein (CCSP) for Clara cells, and fork-
head box J1 (Foxj1) for ciliated cells (32, 33). Future studies will be 
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The apparent difference in survival between constitutive and 
systemically inducible Et2-null mice (Figure 2, C and F) may 
suggest the importance of ET-2 during embryonic development. 
However, it is highly possible that the less severe phenotype of 
inducible Et2-null mice results from the gradual recombination 
of the floxed Et2 gene rather than the effect of ET-2 on embry-
onic development. Although the excision of the floxed gene can 
be induced relatively quickly, the efficiency still depends on time 
and is different in each individual (25). Therefore, the phenotype 
appearance resulting from the gene’s absence will occur gradu-
ally. In our experimental setting, tamoxifen was provided to the 
dam after giving birth, and not during pregnancy. Therefore, the 
recombination efficiency of each Et2f/f;CAGGCre-ERTM pup will 
show big differences depending on its milk consumption. As 
shown in Supplemental Figure 15, six hours after birth, intestinal 
ET-2 is still expressed in some neonatal Et2f/f;CAGGCre-ERTM mice, 
but it is completely lost around 48 hours after birth. This result 
supports our hypothesis that ET-2 action in the postnatal period 
is essential for the growth and survival of the mice.
The results of our mouse genetic study of ET-2 provide insights 
into its potential implication and role in humans. In contrast to 
the intestine-restricted expression in rodents, human ET-2 expres-
sion has been detected in a range of tissues such as heart, lung, 
kidney, vasculature, ovary, and colon (46). Currently, ET receptor 
antagonists such as bosentan and ambrisentan are clinically used 
for the treatment of pulmonary arterial hypertension. However, 
our data showing the possible role of ET-2 in the maintenance of 
lung morphology and function suggest that blocking the ET-2 
signaling pathway may have adverse effects in the lungs of human 
patients. Therefore, the effect of ET antagonists on normal lung 
morphology and basal function should be examined in preclinical 
safety tests in clinical trials. The beneficial effect of bosentan and 
Ro 48-5695 in the rat trinitrobenzene sulfonic acid–induced colitis 
model supports the possible use of ET receptor antagonists in the 
treatment of human inflammatory bowel disease (IBD) (47–49). 
However, a clear role of ET in IBD pathogenesis has not been con-
clusively established (50). Unlike in rats, ET-2 is the predominant 
ET isoform in both mouse (I. Chang et al., unpublished observa-
tions) and human colonic mucosa (50). Therefore, investigating 
a model of intestinal injury and inflammation with Et2f/f;Vil-Cre 
mice would be informative to address the question of whether the 
beneficial effects of ET antagonists reported in the rat model are 
relevant to the treatment of human IBD.
Methods
Animal experiment. Detailed information regarding the generation of the 
constitutive and conditional Et2 knockout mice is described in Supplemen-
tal Data and Supplemental Figure 1. Mice were housed in a temperature-
controlled environment with 12-hour light/dark cycles and were observed 
daily to check for survival. Chow containing 4% fat (Harlan Teklad) and 
water were provided ad libitum. Body weight was recorded every 5 days 
(Figure 2, B and E) or weekly (Figure 2G). Blood glucose levels were assayed 
using a Glucometer Elite XL (Bayer). For serum, blood was collected in 
Vacutainer SST Tubes (BD Biosciences) and centrifuged (1,500 g for 
15 minutes at 4°C), and serum was stored at –20°C until analysis. Serum 
hematocrit was analyzed by the Pathology Laboratory of Dallas Children’s 
Medical Center. Total ketone was measured using an Autokit Total Ketone 
Bodies R1 and R2 Set (Wako Chemicals USA). Total body fat mass was ana-
lyzed by NMR using a Minispec mq spectrometer (Bruker). Tissues were 
harvested and weighed before freezing at –80°C for RNA extraction or 
needed to determine the specific epithelial cell population respon-
sible for ET-2 expression and thus the most appropriate promoter 
for removal of ET-2 in the lung.
In this report, internal starvation, severe hypothermia, and 
lung dysfunction caused by ET-2 deficiency are proposed as pos-
sible independent underlying mechanisms explaining the growth 
retardation and early lethality of Et2-null mice. Nonetheless, it is 
highly possible that these phenotypes are not independent, since 
metabolic rate, body temperature, and breathing regulation are 
physiologically interrelated. First, starvation might be the pri-
mary abnormality caused by the absence of ET-2. Under the stress-
ful environment imposed by reduced food availability and a low 
ambient temperature, small mammals, including mice, can enter 
torpor to conserve energy by dropping their body temperature to 
near-ambient temperature levels (34). Since nutritional availability 
is an important determinant of normal lung development, chronic 
nutrient restriction may induce structural and functional altera-
tions in the lung (35). The lungs of rats starved soon after birth 
exhibit impaired alveolar development and enlarged air spaces 
consistent with the phenotype of Et2-null mice (36). Starvation or 
calorie restriction in adult animals including humans can also lead 
to structural and functional changes in the lung (37). Although 
the lung abnormalities were less marked than what was seen in the 
Et2-null mice, these studies raise the possibility that hypothermia 
and lung dysfunction might be a secondary effect of internal star-
vation due to ET-2 deficiency.
Another possibility is that lung dysfunction is the primary 
abnormality underlying the phenotype of Et2-deficient mice. 
PDGF-A signaling is a critical event in lung alveolar myofibrob-
last development and alveogenesis. The core fucosylation (α1, 
6-fucosylation) of TGF-β1 receptors is crucial for the prevention 
of developmental and progressive/destructive emphysema. Pdgfa 
and α1, 6-fucosyltransferase–null (Fut8-null) mice display air-
space enlargement with the failure of alveolar septation in the lung 
accompanied by postnatal growth retardation and early lethality 
(38, 39). Malnutrition and weight loss are common problems in 
chronic obstructive pulmonary disease (COPD) (40), and signifi-
cant loss of body weight is also observed in mouse models exposed 
to hypoxia (41). Many studies have reported that hypoxia evokes 
a regulated decrease in body temperature (i.e., anapyrexia) as a 
compensatory response to decreased oxygen consumption (42). 
Chronic hypercapnia can impair thermoregulation by increas-
ing sweating and reducing shivering in humans (43). Thus, it is 
quite reasonable to hypothesize that in Et2-null mice, an internally 
starved state and hypothermia are the consequence, and not the 
cause, of severe lung dysfunction and respiratory failure.
Whether or not the profound hypothermia of Et2-null mice is a 
byproduct of internal starvation and lung dysfunction, it is still an 
important contributor to the phenotype. Since Et2-null mice reared 
in warm conditions lived longer than their null littermates housed 
at room temperature (Figure 5F), abnormal thermoregulation may 
play a critical role in the premature death of Et2-null mice. In a cold 
environment, Et2-null mice are unable to maintain body tempera-
ture. Furthermore, hypothermia might not be the consequence of 
torpor, since the expression of pancreatic lipases was paradoxically 
decreased in the liver of Et2-null mice (Supplemental Figure 13), 
whereas an increase in expression is a hallmark of torpor (44, 45). 
Nonetheless, these results deserve cautious interpretation, and this 
hypothesis needs to be explored further, since loss of neuronal ET-2 
does not cause defects in thermoregulation.
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(Ambion) in the presence of 35S-CTP and -UTP (GE Healthcare). Paraf-
fin-embedded sections were prepared from the tissues of WT control and 
Et2-null mice. Following prehybridization, sections were hybridized at 
70°C with sense and antisense riboprobes. Following overnight incuba-
tion, unhybridized probe was removed with stringent washes and treat-
ment with RNase A. Slides were subsequently coated with K.5 nuclear 
emulsion, exposed at 4°C for 4 to 5 weeks, developed, counterstained with 
hematoxylin, and examined using bright- and dark-field optics.
Statistics. Values are presented as the means ± SEM. Statistical signifi-
cance was evaluated by conducting a 2-tailed unpaired Student’s t test 
using Prism 5.0 (GraphPad Software). A P value of less than 0.05 was 
regarded as statistically significant.
Study approval. All animal experiments were approved by the Institutional 
Animal Care and Research Advisory Committee of the University of Texas 
Southwestern Medical Center.
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were fixed in 4% paraformaldehyde for paraffin embedding. For histology, 
5-μm sections were stained with H&E and analyzed by light microscopy. 
For fecal nutrient analysis, stools were collected from individually housed 
mice. Fat content was determined gravimetrically as described (51, 52), and 
carbohydrate amount was determined by a spectrophotometric method 
as described (53). Dietary fat absorption was examined by radioactivity 
of [3H] triolein as described (54). Core body temperature was monitored 
using Thermalert TH-5 with rectal probes or flexible implantable probes 
(Physitemp Instruments) between 11:00 and 14:00. For the survival study 
in a warm environment, 3-week-old mice were housed in a normal envi-
ronment or on a heating pad (Gaymar Industries) to keep the cage floor 
at 33°C. For the temperature preference test, the cage was placed on 2 jux-
taposed heating pads set at 22°C and 33°C (Mediheat V500 Vstat; Peco 
Services Ltd.). One of pads was heated at the designated temperature. Mice 
were videotaped for 1 hour, and the location of the mice was recorded and 
analyzed every 5 minutes using a TopScan Lite (CleverSys). For the cold 
environment challenge experiment of constitutive Et2-null mice, the body 
temperature of 6-week-old Et2-null mice rescued by a warm environment 
was monitored. For blood gas analysis, blood was drawn from the retro-or-
bital plexus into lithium-heparin–coated capillary tubes (Instrumentation 
Laboratory) and analyzed with a STAT profile Critical Care Xpress (Nova 
Biomedical). Real-time oxygen saturation percentage of arterial hemoglo-
bin was measured by MouseOx (STARR Life Sciences Corp.) according to 
the manufacturer’s instructions. Serum erythropoietin was assayed using 
the mouse/rat Quantikine Immunoassay Kit (R&D Systems). Total lung 
capacity was measured using a flexiVent ventilator and software (Scireq 
USA) and normalized to body weight. The preparation of epithelial and 
mesenchymal cell fractions was performed as described (55).
qRT-PCR analysis. Total RNA was extracted from tissues using STAT 60 
(Tel-Test), treated with RNase-free DNase I (Roche Molecular Biochem-
icals), and reverse-transcribed into cDNA with random hexamers (Roche 
Molecular Biochemicals) and the SuperScript II First-Strand Synthesis Sys-
tem (Invitrogen). Real-time PCR reactions contained 25 ng of cDNA, 150 
nM of each primer, and 10 μl of SYBR Green PCR Master Mix (Applied 
Biosystems) in 20 μl of total volume and were performed with an ABI Prism 
7000 Sequence Detection System. Relative mRNA levels were calculated 
with a ddCT method normalized to 18s rRNA levels. Primer sequences were 
designed using Primer Express software (PerkinElmer Life Sciences), and all 
sequences are available as supplemental material (Supplemental Table 2).
In situ hybridization. A 0.45-kb segment of the mouse Et2 gene was PCR 
amplified using 5′-TTTGAATTCAGGCTCCTGCTGCTGTGT-3′ and 
5′-TTTCTCGAGGCATGTTCATTTGTCCTC-3′ as primers and cloned 
into pBluescript II SK (+/–). Sense and antisense riboprobes were gener-
ated with T3 and T7 polymerases, respectively, using the Maxiscript kit 
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